

Bionano Genomics is surging Tuesday as investors weigh its growth strategy and favorable milestones for its genome mapping technology.
You can purchase shares of Bionano Genomics (NASDAQ:BNGO) through any online brokerage.
Other companies in Bionano Genomics’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Bionano Genomics has a consensus price target of $6.00.
The stock price for Bionano Genomics (NASDAQ: BNGO) is $1.1482 last updated November 6, 2026 at 6:18 PM EST.
There are no upcoming dividends for Bionano Genomics.
Bionano Genomics does not have any upcoming earnings scheduled.
There is no upcoming split for Bionano Genomics.
Bionano Genomics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that...